Artidis AG
PrivateLast Round
Seed
Dec 5, 2019
Total Funding Raised
$8.94M
Company Overview
Artidis AG is a Swiss health technology company developing a nanomechanical biomarker platform for cancer diagnosis and treatment optimization.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artidis AG Comparables
Compare Artidis AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellens Inc. | 74% | |
| Guardant Health | 60% | |
| X-ZELL | 59% | |
Artidis AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2019 |
Key People
Founding team and executive leadership
Artidis AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BERNINA BioInvest AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 822% MoM, from 426 to 3.9K.
- Nov 9, 2025
Monthly visitors grew 81% MoM, from 2.2K to 4K.
Artidis AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artidis AG's valuation, stock price, and market status.